BIO vs BSVN · rev $651.0M vs P/E 9.2, rev $64.7M
BIO (BIO) versus Bank7 Corp (BSVN) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
Bank7 Corp (BSVN) is a banks - regional company listed on US.
Latest reported BIO revenue for 2026-06-30 was $651.0M. Net income was $371.4M. Revenue was up 9.9% from 2026-03-31 to 2026-06-30. BIO currently screens at market cap $0.
Latest reported BSVN revenue for 2026-06-30 was $64.7M. Net income was $20.4M. Revenue was up 91.5% from 2026-03-31 to 2026-06-30. BSVN currently screens at market cap $420.2M and trailing P/E 9.2.
BIO currently screens at market cap $0. BSVN currently screens at market cap $420.2M and trailing P/E 9.2.
Not investment advice. Open the BIO and BSVN stock pages for the full models.
Not investment advice.